The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Kaufer, D.
* Articles by Christine, D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Kaufer, D.
* Articles by Christine, D.
Related Collections
* Alzheimer's Disease
J Neuropsychiatry Clin Neurosci 10:55-63, February 1998
© 1998 American Psychiatric Press, Inc.

Differential Neuropsychiatric Symptom Responses to Tacrine in Alzheimer's Disease

Relationship to Dementia Severity

Daniel Kaufer, M.D., Jeffrey L. Cummings, M.D. and Dianne Christine, R.N.

Received January 6, 1997; revised March 19, 1997; accepted March 27, 1997. From the Departments of Neurology and Psychiatry/Biobehavioral Sciences, University of California at Los Angeles School of Medicine; the Behavioral Neuroscience Section, Psychiatry Service, and Nursing Service, West Los Angeles Veterans Affairs Medical Center, Los Angeles, California; and the Departments of Psychiatry and Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Address correspondence to Dr. Kaufer, 4 West ADRC, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213.

Neuropsychiatric symptom responses to tacrine were investigated in an open-label study of Alzheimer's outpatients. Forty subjects were stratified into three groups (Mild, Moderate, and Severe) based on Mini-Mental State Examination scores. A significant reduction in total Neuropsychiatric Inventory score across all subjects was principally attributable to changes in the Moderate group. Apathy and disinhibition symptoms were significantly reduced overall. Whereas other symptoms showed differential responses in Mild and Severe subjects, all symptoms improved in Moderate subjects. These findings suggest that disease severity may significantly influence neuropsychiatric symptom responses to tacrine. Putative mechanisms underlying the observed pattern of responses are explored.

Key Words: Alzheimer's Disease • Tacrine • Treatment Strategies




This article has been cited by other articles:


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
A. M. Landes, S. D. Sperry, and M. E. Strauss
Prevalence of Apathy, Dysphoria, and Depression in Relation to Dementia Severity in Alzheimer's Disease
J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 342 - 349.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
S. L. Griffin, R. van Reekum, and C. Masanic
A Review of Cholinergic Agents in the Treatment of Neurobehavioral Deficits Following Traumatic Brain Injury
J Neuropsychiatry Clin Neurosci, February 1, 2003; 15(1): 17 - 26.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
R. E. Tractenberg, M. F. Weiner, M. B. Patterson, A. Gamst, and L. J. Thai
Emergent Psychopathology in Alzheimer's Disease Patients Over 12 Months Associated with Functional, Not Cognitive, Changes
J Geriatr Psychiatry Neurol, June 1, 2002; 15(2): 110 - 117.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. R. Farlow, A. Hake, J. Messina, R. Hartman, J. Veach, and R. Anand
Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease Progression
Arch Neurol, March 1, 2001; 58(3): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. S. Paulsen, D. P. Salmon, L. J. Thal, R. Romero, C. Weisstein-Jenkins, D. Galasko, C. R. Hofstetter, R. Thomas, I. Grant, and D. V. Jeste
Incidence of and risk factors for hallucinations and delusions in patients with probable AD
Neurology, May 23, 2000; 54(10): 1965 - 1971.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
D. I. Kaufer, J. L. Cummings, P. Ketchel, V. Smith, A. MacMillan, T. Shelley, O. L. Lopez, and S. T. DeKosky
Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory
J Neuropsychiatry Clin Neurosci, May 1, 2000; 12(2): 233 - 239.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. L. Cummings
Cholinesterase Inhibitors: A New Class of Psychotropic Compounds
Am J Psychiatry, January 1, 2000; 157(1): 4 - 15.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
O. L. Lopez, S. R. Wisniewski, J. T. Becker, F. Boller, and S. T. DeKosky
Psychiatric Medication and Abnormal Behavior as Predictors of Progression in Probable Alzheimer Disease
Arch Neurol, October 1, 1999; 56(10): 1266 - 1272.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
P. Chen, M. Ganguli, B. H. Mulsant, and S. T. DeKosky
The Temporal Relationship Between Depressive Symptoms and Dementia: A Community-Based Prospective Study
Arch Gen Psychiatry, March 1, 1999; 56(3): 261 - 266.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org